Bellet, Meritxell, Gray, Kathryn, Gonzales-Martin, Antonio, Ferrer, Roser, Catalan, Roberto, Azaro, Analia, Rajasekaran, Agnita, Morales, Josefa, Vazquez, Josep, Fleming, Gini, Price, Karen, Regan, Meredith, Francis, Prudence, Lang, Istvan, Ciruelos, Eva, Lluch, Ana, Climent, Miguel Angel, Catalan, Gustavo, Avella, Antoni, Bohn, Uriel. American Society of Clinical Oncology; 2016. Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): the SOFT-EST substudy.

De Boer, Richard, Beith, Jane, Zdenkowski, Nicholas, Bell, Richard, Chirgwin, Jacquie, Chua, Sue, Colosimo, Maree, Francis, Prudence, Green, Michael, Pittman, Ken, White, Michelle, Wilcken, Nicholas. Wiley-Blackwell Publishing; 2014. Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives.

Wilcken, Nicholas, Zdenkowski, Nicholas, Chua, Sue, Chirgwin, Jacquie, Beith, Jane, Bell, Richard, White, Michelle, Snyder, Ray, Pittman, Ken, Mainwaring, Paul, Green, Michael, Francis, Prudence, De Boer, Richard, Colosimo, Maree. Wiley-Blackwell Publishing; 2014. Systemic treatment of HER2-positive metastatic breast cancer: a systematic review.

Regan, Megan, Fleming, Gini, Walley, Barbara, Francis, Prudence, Pagani, Olivia. American Society of Clinical Oncology; 2019. Adjuvant systemic treatment of premenopausal women with hormone receptor-positive early breast cancer: lights and shadows.

Loi, Sherene, Drubay, Damien, Gray, Robert, Munzone, Elisabetta, Lemonnier, Jerome, Sotiriou, Christos, Piccart, Martine, Kellokumpu-Lehtinen, Pirkko-Liisa, Vingiani, Andrea, Gray, Kathryn, Andre, Fabrice, Denkert, Carsten, Adams, Sylvia, Salgado, Roberto, Michiels, Stefan, Pruneri, Giancarlo, Francis, Prudence, Lacroix-Triki, Magali, Joensuu, Heikki, Dieci, Maria Vittoria, Badve, Sunil, Demaria, Sandra. American Society of Clinical Oncology; 2019. Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers.

Johansson, Harriet, Gray, Kathryn P., Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A., TEXT principal investigators,, Pagani, Olivia, Chirgwin, Jaqueline, Francis, Prudence, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf. BioMed Central; 2016. Impact of CYO19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.

Pagani, Olivia, Regan, Meredith, Ciruelos, Eva, Stearns, Vered, Bonnefoi, Herve, Martino, Silvana, Geyer, Charles, Pinotti, Graziella, Puglisi, Fabio, Crivellari, Diana, Ruhstaller, Thomas, Winer, ERic, Walley, Barbara, Rabaglio-Poretti, Manuella, Maibach, Rudolf, Ruepp, Barbara, Giobbie-Herder, Anita, Price, Karen, Bernhard, Jurg, Luo, Weixiu, Ribi, Karin, Viali, Guiseppe, Coates, Alan, Fliming, Gini, Gelber, Richard, Goldhirsch, Aron, Francis, Prudence, Colleoni, Marco, Lang, Istvan, Gomez, Henry, Tondini, Carlo, Burstein, Harold, Perez, Edith. Massachusetts Medical Society; 2014. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Zeidan, Youssef, Habib, Joyce, Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Joseph, David, Crown, John, Piccart-Gebhart, Martine, Francis, Prudence, Ameye, Lieveke, Paesmans, Marianne, de Azambuja, Evandro, Gelber, Richard, Campbell, Ian, Nordenskjold, Bo, Gutierez, Jorge, Anderson, Michael. Elsevier; 2018. Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the Breast International Group 02-98 Trial.